08 March 2021>: Articles
Activated Prothrombin Complex Concentrate-Induced Atypical Hemolytic Uremic Syndrome Treated with Eculizumab
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Unexpected drug reactionHsin Hsiang Clarence Tsai C* , Justin Tyler Moyers B , Christie J. Moore B , MieMie Thinn D
Am J Case Rep 2021; 22:e929616
Figure 1. Hemoglobin and platelet count over time by day of admission during hospital course along with temporal relationship of therapeutic interventions (FEIBA, Steroids, Plasma Exchange [PLX], and eculizumab). Each point represents a lab value measurement.